EveryLife Foundation for Rare Diseases

Lobbying

$95,000 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers roughly through Q3, 2012

Lobbying on Behalf of EveryLife Foundation for Rare Diseases

  • Names of Lobbyists
  • Most Frequently Disclosed Lobbying Issues
    • Health Issues
  • Most Frequently Disclosed Bills
    Bill No. Title
    H.R.3737 ULTRA
    H.R.4132 FAST Act
    H.R.5661 To suspend temporarily the rate of duty on 1-Hydroxy cyclohexyl phenyl ketone.
    S.3187 Food and Drug Administration Safety and Innovation Act
View all lobbying data for EveryLife Foundation for Rare Diseases Sources: OpenSecrets.org